Sentinel lymph node biopsy in melanoma patients: An experience with Tc-99m antimony sulfide colloid

Iranian Journal of Nuclear Medicine

Volumn 18, Issue 1, 2010, Pages 1-6

  Mehrabibahar, Mostafa ^a   Forghani, Mohammad Naser ^b   Memar, Bahram ^a   Jangjoo, Ali ^a   Kakhki, Vahid Reza Dabbagh ^c   Zakavi, Seyed Rasoul ^c   Aryana, Kamran ^c   Abdollahi, Abbas ^b   Sadeghi, Ramin ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Melanoma; Sentinel node; Tc 99m antimony sulfide colloid

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DISULFINE BLUE; TRACER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HEAD AND NECK CANCER; HEAD AND NECK MELANOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MICROCOMPUTER; PATHOLOGIST; SENTINEL LYMPH NODE BIOPSY; THICKNESS; TUMOR VOLUME;

EID: 78649292032     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Amouzgar MH, Yazdan Panah MJ, Ebrahimi Rad M. Frequency of different skin cancers in Ghaem hospital, Mashhad, from 1975 to 1995: A cross-sectional study. Iran J Dermatol 2006;35:28-34.
2. Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR.Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res. 2004;14(6):521-526. (Pubitemid 40221144)
3. Sadeghi R, Forghani MN, Zakavi SR, Jangjoo A, Shabani GA, Dabbagh Kakhki VR. The need for skin pen marking for sentinel lymph node biopsy: A comparative study. Iran J Nucl Med 2008;16:23-27.
4. Smylie M, Claveau J, Alanen K, Taillefer R, George R, Wong R et al. Management of malignant melanoma: best practices. J Cutan Med Surg. 2009;13(2):55-73.
5. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005 Sep;242(3):302-11; discussion 311-313.
6. Weiss M, Konz B, Schmid-Wendtner MH, Sander C, Dresel S, Tatsch K et al. Metastases in malignant melanoma despite histologically negative sentinel lymph node: should the concept be changed? Nuklearmedizin. 2000;39(7):214-217.
7. Yao K, Balch G, Winchester DJ. Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009;89(1):267-281.
8. Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A et al. Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer. DARU 2009;17:83-87.
9. Omranipour R. Inguinal sentinel lymph node biopsy with only blue dye in lower extremity malignant melanoma. Tehran Univ Med J 2008;2:80-84.
10. Weiss M, Kunte C, Schmid RA, Konz B, Dresel S, Hahn K. Sentinel node mapping in patients with malignant melanoma using melanoma Tc-99m colloidal rhenium sulfide. Clin Nucl Med. 2003;28(5):379-384.
11. Pfützner W, Kunte C, Weiss M, Flaig MI, Konz B. Intraoperative labeling of sentinel lymph nodes with a combination of vital dye and radionuclide tracer - results in sentinel lymph node-positive patients. J Dtsch Dermatol Ges. 2006;4(3):229-235.
12. 99mTc-antimony sulfide colloid for lymphoscintigraphy. Iran J Nucl Med 2003;19:57-65.
13. Berman CG, Choi J, Hersh MR, Clark RA. Melanoma lymphoscintigraphy and lymphatic mapping. Semin Nucl Med 2000;30:49-55.
14. McMasters KM, Wong SL, Edwards MJ, Ross MI, Chao C, Noyes RD et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery. 2001;130(2):151-156. (Pubitemid 32721662)
15. Easson AM, Rotstein LE, Mc Cready DR. Lymph node assessment in melanoma. J Surg Oncol 2009;99:176-185.
16. Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J et al. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol. 2004;31(3):363-373.
17. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307-1317.
18. Statius Muller MG, van Leeuwen PA, van Diest PJ, Pijpers R, Nijveldt RJ, Vuylsteke RJ et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. World J Surg. 2002;26(12):1405- 1411. (Pubitemid 36920195)
19. Ho Shon IA, Chung DK, Saw RP, Thompson JF. Imaging in cutaneous melanoma. Nucl Med Commun 2008;29:847-876.
20. Ho Shon IA, Chung DK, Saw RP, Thompson JF. Guidelines for imaging in cutaneous melanoma. Nucl Med Commun. 2008;29(10):877-879.
21. Russell-Jones R, Acland K. Sentinel Node Biopsy in the Management of Malignant Melanoma. Clin Exp Dermatol. 2001;26:463-468
22. McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8(3):192-197.
23. Jansen L, Nieweg OE, Kapteijn AE, Valdés Olmos RA, Muller SH, Hoefnagel CA et al. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol. 2000;7(8):624-630.
24. Chakera AH, Lock-Andersen J, Hesse U, Nürnberg BM, Juhl BR, Stokholm KH et al. One-day or two-day procedure for sentinel node biopsy in melanoma? Eur J Nucl Med Mol Imaging. 2009;36(6):928-937.
25. McMasters KM, Chao C, Wong SL, Wrightson WR, Ross MI, Reintgen DS et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137(5):543-7; discussion 547-549.
26. Gow KW, Rapkin LB, Olson TA, Durham MM, Wyly B, Shehata BM. Sentinel lymph node biopsy in the pediatric population. J Pediatr Surg. 2008;43(12):2193-2198.
27. Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FG, Muzikansky A et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110(3):614-624. (Pubitemid 47106151)
28. Shah NC, Gerstle JT, Stuart M, Winter C, Pappo A. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. J Pediatr Hematol Oncol. 2006;28(8):496-500.
29. Silverio AM, McRae MC, Ariyan S, Narayan D. Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma. Ann Plast Surg. 2009;62(5):564-569.